Search Beyond News…

Quay gains visibility as Consumer365 names its prescription sunglasses among the top fashion‑forward frames for 2026

Executive summary: Consumer365 published a 2026 feature naming Quay among the best prescription sunglasses for everyday wear and versatile personal style. The endorsement raises Quay’s profile in the prescription eyewear segment and could influence consumer purchasing decisions.

Who is involved: Consumer365 (publisher) and Quay (eyewear brand).

Likely next: Quay may use the recognition in promotional efforts, potentially boosting sales and prompting competitors to seek similar media placements.

Consumer365’s 2026 review of the best prescription sunglasses highlighted Quay for offering stylish, fashion‑forward RX frames suitable for everyday wear and versatile personal style. The feature focuses on the brand’s prescription‑ready designs and lens options, positioning Quay within the competitive eyewear market. While the recognition is a positive endorsement, its direct impact on sales will depend on how Quay leverages the coverage in its marketing and distribution channels.

What's next — scenarios

Base: modest sales uplift (60%)

Quay sees a slight increase in prescription sunglasses sales as the feature reaches its target audience.

Upside: broader distribution deals (25%)

The visibility leads to new retail partnerships or expanded shelf space for Quay’s prescription frames.

Downside: limited impact (15%)

The feature generates little measurable change in Quay’s sales or brand perception.

Timeline

Analysis — what this means

Sectors affected

Sources

Browse the full archive →